Today's Big Stories

ARVs soon to be available to all HIV patients, irrespective of CD4 count

Health Minister Aaron Motsoaledi has announced that all HIV-positive South Africans will have access to anti-retroviral drugs (ARVs) by September this year.

The CD4 eligibility criterion for ARV medication will be removed from healthcare policies after clinical evidence showed the benefits of early treatment.

Leading HIV scientist Professor Salim Abdool Karim says that early treatment will reduce the chances of contracting an infectious disease or developing an AIDS-related illness.

We now know that these patients will do better. They will have fewer episodes of TB, fewer events relating to HIV such as pneumonia or meningitis, and they will have a close to normal life span.

Professor Salim Abdool Karim, Director for the Centre for Aids Program of Research in South Africa

In addition, early treatment may provide preventative benefits as the ARVs decrease a patient's level of infectiousness.

Listen to the full conversation from The Midday Report:


Recommended

by NEWSROOM AI
Read More
New calls for medical aid schemes to pay for HIV prevention drugs

New calls for medical aid schemes to pay for HIV prevention drugs

Medical aid companies stand to benefit from preventative HIV care packages for clients, says healthcare funder Dr Humphrey Zokufa.

Drugs will reduce risk of getting HIV - Health department on board

Drugs will reduce risk of getting HIV - Health department on board

The use of ARV's as a pre-exposure drug has proved highly effective in reducing the risk of people contracting HIV.

Male sexual health and the new HIV preventive drug explained

Male sexual health and the new HIV preventive drug explained

Dr Shingai Mutambirwa tackles listeners' questions on male sexual health and talks about Truvada, the new HIV preventive drug.

Medicines Control Council approves HIV prevention drug

Medicines Control Council approves HIV prevention drug

In a ground-breaking development, South Africans will have access to Truvada, a new drug that will reduce their chances of HIV infection.

'We need to refocus on prevention of HIV infections' - Prof Helen Rees

'We need to refocus on prevention of HIV infections' - Prof Helen Rees

The Wits Reproductive Health and HIV Institute's Professor Helen Rees says we need to refocus on prevention of HIV infections.

Fewer deaths in SA than any time since 2001 (and 4 other insights from Stats SA)

Fewer deaths in SA than any time since 2001 (and 4 other insights from Stats SA)

Flu kills more South Africans of all ages than HIV. This and other surprising insights from Stats SA’s latest mortality report.

Popular articles
'Reason for Mabuza's swearing-in postponement is BS' says Eusebius

'Reason for Mabuza's swearing-in postponement is BS' says Eusebius

He believes these things are about power, horsetrading, and skeletons that these people know they have.

Dis-Chem drives ad expert to 'Steve Hofmeyr-like assaults' on his decoder

Dis-Chem drives ad expert to 'Steve Hofmeyr-like assaults' on his decoder

"It’s been said you can’t bore people into buying your brand. Someone should’ve pointed this out to Dis-Chem," says Andy Rice.

Bone-dry Makhanda (Grahamstown) is falling apart

Bone-dry Makhanda (Grahamstown) is falling apart

What is going on in bone-dry Makhanda (Grahamstown)? Bruce Whitfield interviews Jacko Maree (St Andrew's College).

Brilliant graduate gets 50% scholarship to study in France. Can you help?

Brilliant graduate gets 50% scholarship to study in France. Can you help?

Paris-Sorbonne University accepted Khumo Mampuru into its master’s in quantitative economics course, but he’s €12 000 short.

'BEE has closed many avenues for skilled people'

'BEE has closed many avenues for skilled people'

Africa Melane speaks to EOSA's Johannes Wessels about why so many highly skilled South Africans are taking their talents overseas.

'Public Protector is protector of something, but not protector of the public'

'Public Protector is protector of something, but not protector of the public'

Scorpio investigative journalist Pauli van Wyk and independent legal consultant Phephelaphi Dube analyse the events.

Standard Bank takes on Capitec Bank with low-fee account, gigabytes of free data

Standard Bank takes on Capitec Bank with low-fee account, gigabytes of free data

The account costs R4.95 per month; you get 1GB of free data. Swipe 4 times a month; you get 0.5GB of free data and R50 airtime.